AcquisitionHealthcare & Life Sciences
Zenex buys SAVAVET pet care business
By Abha Lohia · Editor ·
Zenex Animal Health: revenue and funding and every story →
Ahmedabad
- Zenex makes veterinary medicines for livestock, poultry and pets, and is backed by private equity investor Multiples
- It has bought SAVAVET, the companion animal unit of SAVA Healthcare, on an undisclosed price
- SAVAVET sells about 70 brands through 165 stockists and more than 6,000 vets, making this Zenex's third buyout under Multiples
What happened
- Zenex has bought SAVAVET, the pet care arm of SAVA Healthcare.
- The price was not disclosed.
- It is Zenex's third acquisition since Multiples invested.
- Earlier deals were Ayurvet and VievePharma.
- SAVAVET sells about 70 brands.
Why it matters
- Pet healthcare is one of the fastest-growing parts of India's animal health market.
- The deal gives Zenex established brands and vet ties.
- SAVA Healthcare can focus on human health.
The business
- Zenex makes and sells animal medicines and feed supplements for livestock, poultry and pets.
- Its range covers antibiotics, vitamin injections, hormones, udder-infection treatments, poultry vaccines and growth promoters.
- It makes products at its Haridwar plant and sells to farmers and vets through a field team of 1,200+ sales staff.
- It earns by selling these products in India and in 15+ export countries across the Middle East, Africa, Eastern Europe and Southeast Asia.
- Revenue was about ₹1,023 crore in FY 2025, up 24% on the year before.
- In 2026 it bought a majority of a Dutch animal nutrition firm, widening its reach abroad.
Who put in money
- Multiples Alternate Asset Management private equity investor — Invested in Zenex before its recent buyouts.
In numbers
₹1,023 CrRevenue · FY2025
1,200+Sales staff · 2026
15+Export countries · 2026
1,626Employees · 2025
Earlier rounds
- Dec 2021: IFC and Emerging Asia Fund proposed to buy up to $52.5 million of shares from Multiples PE Fund III (about $16 million IFC, $36.5 million EAF)
- Multiples PE, with other investors, backs the company after it was formed by buying Zydus Animal Health and Investment, a former Cadila Healthcare unit
Up against
Boehringer IngelheimElancoZoetisAlltechBayer
The numbers around it
Zenex Animal Health has 1 funding rounds in StopDown's archive.
| When | Round | Amount | Led by |
|---|---|---|---|
| 6 December 2021 | Growth equity | $52.5 million | Undefined |
Healthcare & Life Sciences in September 2026: 11 rounds with a disclosed amount, $114 million in all; the biggest was Ultrahuman ($70 mn). Every sector this year →
Terms in this story
- Private equity: Venture capital backs young companies that could grow very fast, taking small stakes and accepting that many will fail, while private equity backs mature companies, often with large or controlling stakes and steadier returns. In India both usually invest through SEBI-registered AIFs, with venture capital funds in Category I and most private equity in Category II.
- Strategic vs financial sale: A strategic sale is when a startup is sold to another operating company that wants its product, customers or team. A financial sale is when it is sold to an investor, usually a private equity fund, that wants a return on the money it puts in. The buyer type changes the price, the terms and what happens to founders and staff afterwards.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on Zenex Animal Health → · All startup news on 30 September 2026 →
Is this Zenex Animal Health? Get your “Featured on StopDown” badge →